The national patent number is ZL9810466 what is 4

Updated on Financial 2024-05-06
3 answers
  1. Anonymous users2024-02-09

    Shen 0 2 0 2 0 2 0 2 0 2 Please 0 2 0 2 0 2 0 2 No.: 0 Shen 0 2 0 2 Please 0 2 0 2 Day: 0 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2

    0 2** Tumor antigen peptide in sart 1 0 2 open 0 2 (announcement) 0 2 No.: 0 2cn1315960 public (announcement) day: 0 main 0 2 points 0 2 class 0 2:

    0 2C07K7 06 Divisional Original Application No.: 0 2 Points 0 2 0 2 0 2 Class 0 2 0 2 0 2 No.: 0 2C07K7 06; a61k38/08;c12n15/12;c07k16/18;c12n5/10;a61k35/14;C12P21 02 0 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0

    0 2 0 2 0 2 0 2 0 2 0 2 0 2 2 Right: 0 JP 196152 1998 Applicant (Patent): 0 2 Ito 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 2 0 2 0 2 2 0 2 0 2 2 0 2 2 0 2 0 2 2 0 2 0 2 0 2 2 0 2 2 0 2 0 2 2 0 2 0 2 0 2 0 2 2 0

    0 2 Japan Saga Prefecture 0 2 Ming 0 2 (design) people: 0 2 Kyogo Ito; Nakao Shinshu 0 2 International Application: 0 2pct JP99 03659 National 0 2 0 2 International 0 2 0 2 2 2 0 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 0 2 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 0 2 2 0 2 2 0 2 2 0 2 2 0 2 2 2 0 2 2 2

    0 2wo00 02907 Date of Entry: 0 Patents 0 2** 0 2 Institutions: 0 2 China Patents** (Hong Kong) **** Generation 0 2 0 2 0 2 0 2 0 2 0 2 0 2 2 2 0 2 2 People:

    0 2 Lu Xinhua; Yang Liqin 0 2 0 2 0 2 Abstract 0 2 Tumor antigen peptide derived from SART 1 and its derivative with equivalent functional properties, or tumor ** agent or prophylactic agent with the tumor antigen peptide.

  2. Anonymous users2024-02-08

    54] Name ** Tumor antigen peptide of sart-1.

    22] Publication 20011003 [21] Publication No. CN1315960

    22] Application Date 19990707 [21] Application No. CN99810466

    30] Priority JP 1961521998

    Cited in the same family.

    71] Applicant: Kyogo Ito.

    Address: Saga Prefecture, Japan.

    72] Inventor Kyogo Ito; Nakao Shinshu.

    51] Main classification C07K007 06

    Subclass C07K007 06; a61k038/08; c12n015/12; c07k016/18; c12n005/10; a61k035/14

    Other Categories 57] Abstract.

    Tumor antigenic peptides derived from SART-1 and their derivatives with functionally equivalent properties, or tumor ** agents or prophylactic agents with the application of the tumor antigenic peptide.

    Claims Claim 1Tumor antigen peptides and their functionally equivalent derivatives contain all or part of any amino acid sequence in sequence number 1 5 and are recognized by cytotoxic T cells when bound to the HLA-A24 antigen.

    Legal Status: Withdrawal (20050518) of a patent is a failure to grant.

  3. Anonymous users2024-02-07

    Summary. The national patent is a national authorization and patent of Jinmu Renxinkang-Bacillus subtilis, which literally refers to exclusive rights and interests. The word patent** in Latin means a public letter or public document, which was used by medieval monarchs to promulgate a certain kind of privilege, and later referred to a certificate of exclusive rights signed by the King of England himself.

    In modern times, patents are generally made up of ** organs or regional organizations representing a number of countries, what kind of patents is the country?

    The national patent is a national authorization and patent of Jinmu Renxinkang-Bacillus subtilis, which literally refers to exclusive rights and interests. The word patent** in Latin means a public letter or public document, which was used by medieval monarchs to promulgate a certain kind of privilege, and later referred to a certificate of exclusive rights signed by the King of England himself. In modern times, patents are generally made by ** agencies or regional organizations representing several countries, Renxinkang's eight advantages of Bacillus subtilis thrombolytic enzyme directly dissolves the main substance of thrombosis - cross-linked fibrin.

    Resistance to gastric acid and antioxidation: Bacillus subtilis thrombolytic enzyme is resistant to gastric acid and antioxidation, and can maintain intact activity with higher specificity. <>

    If you have any other questions, please ask me, thank you.

    Want to inquire about the legitimacy of this platform?

    Pro态Microecology This platform is legitimate态

Related questions
8 answers2024-05-06

Name: Multifunctional battery repair instrument.

Application (Patent) No.: Application Date: >>>More

4 answers2024-05-06

Long-term use of ***.

4 answers2024-05-06

There is this patent, but not solar.

Application No.: Date of Application: >>>More

5 answers2024-05-06

A new type of tap water purification unit.

Application No.: Application Date: 2013-09-12 >>>More

24 answers2024-05-06

This is an invention patent, and the current legal status is: Granted. >>>More